| 标题 |
Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab |
| 备注 |
求正式发表版本的完整正文PDF,须与本题目和DOI/PMID一致。
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI | |
| 其它 | Philippe Sultanik et al. PMID: 38548580. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)